Blau, Jenny E.

Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data

Blau, J. E., Tella, S. H., Taylor, S. I., & Rother, K. I. (2017) · Diabetes/Metabolism Research and Reviews

Diabetes Treatment and ManagementPharmacovigilance and Adverse Drug Reactions

Cited by 271

Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study

Blau, J. E., Bauman, V., Conway, E. M., Piaggi, P., Walter, M. F., Wright, E. C., Bernstein, S., Courville, A. B., Collins, M. T., Rother, K. I., et al. (2018) · JCI Insight

Parathyroid Disorders and TreatmentsBone health and osteoporosis research

Cited by 172

SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: Balancing benefits and risks

Taylor, S. I., Blau, J. E., Rother, K. I., & Beitelshees, A. L. (2019) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 124

Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism

Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine

Hormonal Regulation and HypertensionPancreatic function and diabetes

Cited by 20

Long-Term Immunosuppression After Solitary Islet Transplantation Is Associated With Preserved C-Peptide Secretion for More Than a Decade

Blau, J. E., Abegg, M. R., Flegel, W. A., Zhao, X., Harlan, D. M., & Rother, K. I. (2015) · American Journal of Transplantation

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 15